socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Wednesday, September 27, 2006

    FDA Approves Amgen's Vectibix
    The U.S. Food and Drug Administration said Wednesday that the agency has approved Thousand Oaks-based Amgen's Vectibix treatment for colorectal cancer. Vectibix is a human monoclonal antibody for treatment of patients with epidermal growth factor receptor-(EGFr) expressing metastatic colorectal cancer. Amgen said that Vectibix is expected to be commercially availabile in early to mid October. Vectibix is expected to compete with Erbitux, a drug from ImClone Systems.
    posted on Wednesday, September 27, 2006

    Related stories:

    RSS subscri be via emailEmail


    Previous news:

     Tuesday, October 14, 2008
    Monday, October 13, 2008
    Friday, October 10, 2008
    Thursday, October 9, 2008
    Wednesday, October 8, 2008